Parallel Advisors, LLC Viking Therapeutics, Inc. Transaction History
Parallel Advisors, LLC
- $4.34 Billion
- Q4 2024
A detailed history of Parallel Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 827 shares of VKTX stock, worth $24,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
827
Previous 1,043
20.71%
Holding current value
$24,950
Previous $66,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VKTX
# of Institutions
470Shares Held
63.8MCall Options Held
5.76MPut Options Held
3.43M-
Vanguard Group Inc Valley Forge, PA10.2MShares$307 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$182 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$141 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$63.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$56.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.31B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...